Suppression of Depleted Uranium-Induced Neoplastic Transformation of Human Cells by the Phenyl Fatty Acid, Phenyl Acetate: Chemoprevention by Targeting the p21RAS Protein Pathway

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Radiation Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1667/0033-7587(2001)155[0163:SODUIN]2.0.CO;2PMID 11121229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride.

  1998influential reference
• Urinary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets.

  1998cited by this paper
• Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrate.

  1997cited by this paper
• Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.

  1997cited by this paper
• Up-regulation and functional role of p21Waf1/Cip1 during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate.

  1996cited by this paper
• Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate.

  1996cited by this paper
• Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs.

  1996cited by this paper
• Phenylacetate in chemoprevention: in vitro and in vivo suppression of 5-aza-2'-deoxycytidine-induced carcinogenesis.

  1995cited by this paper
• Phase I study of phenylacetate administered twice daily to patients with cancer

  1995cited by this paper
• Transcriptional upregulation of TGF-alpha by phenylacetate and phenylbutyrate is associated with differentiation of human melanoma cells.

  1995cited by this paper
• Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.

  1994cited by this paper
• A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.

  1994influential reference
• Inhibitory effects of Rooibos tea, Aspalathus linealis, on X-ray-induced C3H10T1/2 cell transformation.

  1994cited by this paper
• Plutonium-catalyzed oxidative DNA damage in the absence of significant alpha-particle decay.

  1994cited by this paper
• Transformation of human osteoblasts to anchorage-independent growth by insoluble nickel particles.

  1994cited by this paper
• Transformation of immortal, non-tumorigenic osteoblast-like human osteosarcoma cells to the tumorigenic phenotype by nickel sulfate.

  1993cited by this paper
• Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.

  1993cited by this paper
• Increased radioresistance of ejras‐transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation

  1993cited by this paper
• Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate.

  1992cited by this paper
• Chemoprevention clinical trials.

  1992cited by this paper
• Phenylacetate: a novel nontoxic inducer of tumor cell differentiation.

  1992cited by this paper
• Cancer prevention: recent progress and future opportunities.

  1991cited by this paper
• Kinetic Energy Penetrator Long Term Strategy Study

  1990cited by this paper
• Health Risks of Radon and Other Internally Deposited Alpha-Emitters (Beir IV)

  1988cited by this paper
• Inhibition of 12-O-tetradecanoylphorbol-13-acetate-enhanced transformation in vitro by radical scavengers.

  1987cited by this paper
• A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy.

  1987cited by this paper
• Fission-spectrum neutrons at reduced dose rates enhance neoplastic transformation

  1982cited by this paper
• Transformation of human cells in culture by N-methyl-N′-nitro-N-nitrosoguanidine

  1975cited by this paper
• Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division.

  1973cited by this paper

• Assess human blood uranium levels of some Iraqi companies.

  2024cites this paper
• Increased PTEN gene expression in patients with endometrial carcinoma from areas of high risk depleted uranium exposure

  2019cites this paper
• SOME AROMATIC AMINES AND RELATED COMPOUNDS VOLUME 127 IARC MONOGRAPHS ON THE IDENTIFICATION OF CARCINOGENIC HAZARDS TO HUMANS

  2019cites this paper
• Radiation protection and mitigation potential of phenylbutyrate: delivered via oral administration

  2017cites this paper
• Chapter 59 – Uranium∗

  2015cites this paper
• Radioprotection by the histone deacetylase inhibitor phenylbutyrate

  2011cites this paper
• Cytogenetic biomonitoring of inhabitants of a large uranium mineralization area: the municipalities of Monte Alegre, Prainha, and Alenquer, in the State of Pará, Brazil

  2010cites this paper
• The Toxicity of Depleted Uranium

  2010cites this paper
• Maladies non diagnostiquées et guerre radiologique

  2009cites this paper
• CHAPTER 45 – Uranium

  2007cites this paper
• The Evolution of Depleted Uranium as an Environmental Risk Factor: Lessons from Other Metals

  2006cites this paper
• Radiation- and Depleted Uranium-Induced Carcinogenesis Studies: Characterization of the Carcinogenic Process and Development of Medical Countermeasures

  2005cites this paper
• Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model.

  2005cites this paper
• DEPLETED AND NATURAL URANIUM: CHEMISTRY AND TOXICOLOGICAL EFFECTS

  2004cites this paper
• Health Risks of Depleted Uranium An Independent Review of the Scientific Literature

  2004cites this paper
• Undiagnosed Illnesses and Radioactive Warfare

  2003cites this paper
• Estimate of the time zero lung burden of depleted uranium in Persian Gulf War veterans by the 24-hour urinary excretion and exponential decay analysis.

  2003cites this paper
• Genomic instability in human osteoblast cells after exposure to depleted uranium: delayed lethality and micronuclei formation.

  2003cites this paper
• Undiagnosed illnesses and radioactive warfare.

  2003cites this paper
• Observation of radiation-specific damage in human cells exposed to depleted uranium: dicentric frequency and neoplastic transformation as endpoints.

  2002cites this paper
• Depleted uranium—the growing concern

  2002influential citation
• Depleted uranium-catalyzed oxidative DNA damage: absence of significant alpha particle decay.

  2002cites this paper
• Biological effects of embedded depleted uranium (DU): summary of armed forces radiobiology research institute research.

  2001cites this paper
• The Health Hazards of Depleted Uranium Munitions Part I

  2001cites this paper